This Week in Nephrology — May 14, 2026

Welcome to This Week in Nephrology. This week we're covering 8 notable papers spanning new insights into disease pathophysiology, advances in diagnostics, and modernizing our therapeutic approaches. Let's dive in. [PAUSE] First, we'll look at a few… This week's papers: 1. Weight Loss-Independent Mechanisms of Kidney Protection with Glucagon-Like Peptide-1 Receptor Agonists and Implications for Clinical Practice. — American journal of kidney diseases : the official journal of the National Kidney Foundation 2026 2. Clinical Relevance of Donor-Derived cfDNA In Monitoring Kidney Transplant Rejection. — Journal of the American Society of Nephrology : JASN 2026 3. Lineage and organ signals sequentially build organ intrinsic nervous systems. — Nature 2026 4. Risk of Serious Adverse Events and Death With Low-Dose Methotrexate Versus Hydroxychloroquine in Adults Receiving Dialysis. — Seminars in dialysis 2026 5. Anti-neutrophil cytoplasmic antibody-associated vasculitis: biological insights and biomarker-guided disease management. — Nature reviews. Nephrology 2026 6. Tubulointerstitial diseases: an updated framework for diverse and emerging entities. — Kidney international 2026 7. Purine Metabolism Regulates the Severity of APOL1 Nephropathy. — Journal of the American Society of Nephrology : JASN 2026 8. Comparative Analysis of Lupus Nephritis Guidelines: ACR 2025, EULAR 2025, and Kdigo 2024. — Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2026 Listen at https://audioscholar.cc/episode/qkq6xwbk4m